![](/img/cover-not-exists.png)
2622 A Phase I/II study to assess the safety and efficacy of pazopanib (paz) and pembrolizumab (pembro) in patients (pts) with advanced renal cell carcinoma (aRCC)
McDermott, D.F., Infante, J.R., Chowdhury, S., Voss, M.H., Motzer, R.J., Perini, R.F., Morosky, A., Zheng, F.F., White, B.C., Wang, Q., Jewell, R.C., Rini, B.I.Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)31440-x
Date:
September, 2015
File:
PDF, 72 KB
english, 2015